Abbott Laboratories (ABT) Stock Statistics & Valuation Metrics

Abbott Laboratories has a market cap or net worth of CHF 159.22B. The enterprise value is CHF 199.21B.

Market Cap

CHF 159.22B

Enterprise Value

CHF 199.21B

Abbott Laboratories has 1,731,941,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,731,941,700

Owned by Insiders

0.48%

Owned by Institutions

54.33%

Abbott Laboratories’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.43%.

Return on Equity (ROE)

0.13

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

8.43%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

385.46K

Profits Per Employee

56.73K

Employee Count

115,000

Asset Turnover

0.51

Inventory Turnover

3.04

The current PE Ratio of Abbott Laboratories is 40.50. Abbott Laboratories’s PEG ratio is -0.61.

PE Ratio

40.50

PS Ratio

3.93

PB Ratio

3.72

Price to FCF

28.03

Price to Operating Cash Flow

21.42

PEG Ratio

-0.61

In the last 12 months, Abbott Laboratories had revenue of 44.33B and earned 6.52B in profits. Earnings per share was 3.74.

Revenue

44.33B

Gross Profit

24.61B

Operating Income

8.05B

Pretax Income

8.47B

Net Income

6.52B

EBITDA

11.92B

Earnings Per Share (EPS)

3.74

In the last 12 months, operating cash flow was 8.86B and capital expenditures -2.10B, giving a free cash flow of 6.76B billion.

Operating Cash Flow

8.86B

Free Cash Flow

6.76B

Free Cash Flow per Share

3.90

Abbott Laboratories pays an annual dividend of CHF 0.52, resulting in a dividend yield of 2.47%

Dividend Per Share

CHF 0.52

Dividend Yield

2.47%

Payout Ratio

45.57%

Free Cash Flow Yield

3.55%

Earnings Yield

2.47%

Beta

0.12

52-Week Price Change

-8.08%

50-Day Moving Average

85.10

200-Day Moving Average

80.33

Relative Strength Index (RSI)

63.31

Average Volume (3m)

―

Abbott Laboratories upcoming earnings date is Jan 27, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 21, 2026

Next Earnings Date

Jan 27, 2027

Ex-Dividend Date

Jul 15, 2026

Abbott Laboratories as a current ratio of 1.58, with Debt / Equity ratio of 28.90%

Current Ratio

1.58

Quick Ratio

1.18

Debt to Market Cap

0.06

Net Debt to EBITDA

0.55

Interest Coverage Ratio

23.60

In the past 12 months, Abbott Laboratories has paid 1.94B in taxes.

Income Tax

1.94B

Effective Tax Rate

0.23

Abbott Laboratories EV to EBITDA ratio is 19.64, with an EV/FCF ratio of 32.18.

EV to Sales

4.51

EV to EBITDA

19.64

EV to Free Cash Flow

32.18

EV to Operating Cash Flow

24.56

Abbott Laboratories has CHF 4.30B in cash and marketable securities with CHF 31.16B in debt, giving a net cash position of -CHF 26.86B billion.

Cash & Marketable Securities

CHF 4.30B

Total Debt

CHF 31.16B

Net Cash

-CHF 26.86B

Net Cash Per Share

-CHF 15.51

Tangible Book Value Per Share

-CHF 0.35

Gross margin is 57.04%, with operating margin of 15.00%, and net profit margin of 9.75%.

Gross Margin

57.04%

Operating Margin

15.00%

Pretax Margin

13.61%

Net Profit Margin

9.75%

EBITDA Margin

22.96%

EBIT Margin

15.09%

The average price target for Abbott Laboratories is CHF 100.64, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

CHF 100.64

Price Target Upside

10.59% Upside

Analyst Consensus

Strong Buy

Analyst Count

19

Revenue Growth Forecast

3.17%

EPS Growth Forecast

-68.71%

Smart Score

7

AI Score

―